BECN1 and cancer: Despite this peptide has been recommended for inducing autophagy as a therapeutic strategy for pathologies such as Huntington’s disease or cancer [13], Tat-BECN1 could also promote toxicity (autosis) in a concentration dependent manner that is cell type specific.